Search Results

There are 75255 results for: content related to: Efficacy of Rifaximin in Prevention of Travelers' Diarrhea: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

  1. You have free access to this content
    Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 11, June 2010, Pages: 1155–1164, P. LAYER and V. ANDRESEN

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04296.x

  2. You have free access to this content
    Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico

    Journal of Travel Medicine

    Volume 17, Issue 2, March/April 2010, Pages: 111–117, Francisco Martinez-Sandoval, Charles D. Ericsson, Zhi-Dong Jiang, Pablo C. Okhuysen, Juan H.M. Meléndez Romero, Norma Hernandez, William P. Forbes, Audrey Shaw, Enoch Bortey and Herbert L. DuPont

    Version of Record online : 24 JAN 2010, DOI: 10.1111/j.1708-8305.2009.00385.x

  3. You have free access to this content
    Expert Review of the Evidence Base for Prevention of Travelers’ Diarrhea

    Journal of Travel Medicine

    Volume 16, Issue 3, May/June 2009, Pages: 149–160, Herbert L. DuPont, Charles D. Ericsson, Michael J. G. Farthing, Sherwood Gorbach, Larry K. Pickering, Lars Rombo, Robert Steffen and Thomas Weinke

    Version of Record online : 19 MAR 2009, DOI: 10.1111/j.1708-8305.2008.00299.x

  4. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 11–26, J. S. Bajaj

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13435

  5. The Effect of Multiple-Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1361–1369, Dr. Helen S. Pentikis, Dr. Margaret Connolly, Dr. Carol B. Trapnell, Dr. William P. Forbes and Dr. Doug K. Bettenhausen

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1361

  6. You have free access to this content
    A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Rifaximin for the Prevention of Travelers' Diarrhea in US Military Personnel Deployed to Incirlik Air Base, Incirlik, Turkey

    Journal of Travel Medicine

    Volume 17, Issue 6, November/December 2010, Pages: 392–394, Adam W. Armstrong, Sefa Ulukan, Matthew Weiner, Manal Mostafa, Hind Shaheen, Isabelle Nakhla, David R. Tribble and Mark S. Riddle

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1708-8305.2010.00462.x

  7. You have free access to this content
    Review article: the antimicrobial effects of rifaximin on the gut microbiota

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 3–10, H. L. DuPont

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13434

  8. You have free access to this content
    Targeting of Rifamycin SV to the Colon for Treatment of Travelers' Diarrhea: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

    Journal of Travel Medicine

    Volume 21, Issue 6, November/December 2014, Pages: 369–376, Herbert L. DuPont, AnnKatrin Petersen, Jeff Zhao, Arley Mundt, Zhi-Dong Jiang, Stephan Miller, Jose Flores, Reshma Shringarpure, Luigi Moro, Robert G. Bagin, E. David Ballard and Mark C. Totoritis

    Version of Record online : 27 OCT 2014, DOI: 10.1111/jtm.12168

  9. Rifaximin for the Treatment of Hepatic Encephalopathy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 8, August 2008, Pages: 1019–1032, Dr. Kenneth R. Lawrence and Dr. Jacqueline A. Klee

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.8.1019

  10. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 37–49, M. Pimentel

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13437

  11. You have free access to this content
    Expert Review of the Evidence Base for Self-Therapy of Travelers’ Diarrhea

    Journal of Travel Medicine

    Volume 16, Issue 3, May/June 2009, Pages: 161–171, Herbert L. DuPont, Charles D. Ericsson, Michael J. G. Farthing, Sherwood Gorbach, Larry K. Pickering, Lars Rombo, Robert Steffen and Thomas Weinke

    Version of Record online : 19 MAR 2009, DOI: 10.1111/j.1708-8305.2009.00300.x

  12. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 3, March 2016, Pages: 300–316, Anastasia Rivkin and Sergey Rybalov

    Version of Record online : 11 MAR 2016, DOI: 10.1002/phar.1712

  13. You have free access to this content
    A Randomized, Double-Blind, Pilot Study of Rifaximin 550 mg Versus Placebo in the Prevention of Travelers' Diarrhea in Mexico During the Dry Season

    Journal of Travel Medicine

    Volume 18, Issue 5, September/October 2011, Pages: 333–336, Jose Flores, Herbert L. DuPont, Zhi-Dong Jiang, Pablo C. Okhuysen, Juan H. Melendez-Romero, Alexei Gonzalez-Estrada, Ismael Carrillo and Mercedes Paredes

    Version of Record online : 1 AUG 2011, DOI: 10.1111/j.1708-8305.2011.00549.x

  14. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

    Sleep and Biological Rhythms

    Volume 10, Issue 2, April 2012, Pages: 145–153, Leonard B WEINSTOCK and Suzie ZEISS

    Version of Record online : 4 MAR 2012, DOI: 10.1111/j.1479-8425.2012.00537.x

  15. You have free access to this content
    The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 8, October 2007, Pages: 1147–1161, E. HUANG, E. ESRAILIAN and B. M. R. SPIEGEL

    Version of Record online : 9 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03464.x

  16. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia

    Liver International

    Volume 32, Issue 3, March 2012, Pages: 467–475, Georgios N. Kalambokis, Athanasia Mouzaki, Maria Rodi and Epameinondas V. Tsianos

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02650.x

  17. Rifaximin exerts beneficial effects in PI-IBS mouse model beyond gut microbiota

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 1 JUN 2017, Yu Jin, Xiaoyang Ren, Gangping Li, Ying Li, Lei Zhang, Huan Wang, Wei Qian and Xiaohua Hou

    DOI: 10.1111/jgh.13841

  18. Determination of rifaximin in rat serum by ionic liquid based dispersive liquid–liquid microextraction combined with RP-HPLC

    Journal of Separation Science

    Volume 35, Issue 15, August 2012, Pages: 1945–1952, Ramisetti Nageswara Rao, Rajavarapu Mastan Vali and Alamanda Vara Prasada Rao

    Version of Record online : 2 JUL 2012, DOI: 10.1002/jssc.201200202

  19. You have free access to this content
    Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 1000–1006, M. Furnari, A. Parodi, L. Gemignani, E. G. Giannini, S. Marenco, E. Savarino, L. Assandri, V. Fazio, D. Bonfanti, S. Inferrera and V. Savarino

    Version of Record online : 18 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04436.x

  20. Prevention and Treatment of Travelers' Diarrhea

    Evidence-Based Gastroenterology and Hepatology, Third Edition

    John WD McDonald, Andrew K Burroughs, Brian G Feagan, M Brian Fennerty, Pages: 324–334, 2010

    Published Online : 22 JUL 2010, DOI: 10.1002/9781444314403.ch19